SOVREMENNAYA PEDIATRIYA.2017.8(88):106-110; doi 10.15574/SP.2017.88.106

Mokiya-Serbina S. A.
SI «Dnipropetrovsk Medical Academy of Health Ministry of Ukraine», Kryvyi Rih

The lecture is devoted to an actual interdisciplinary problem — to the management of atopic dermatitis in children. The presented materials show the result of the analysis of modern clinical recommendations for diagnosis and therapy of atopic dermatitis and scientific research data. The lecture outlines the basic principles of modern therapy, allowing the doctor not only to correctly orientate in the choice of drug, but also to develop a strategy and tactics for treating a sick child, taking into account its individual characteristics.
Key words: atopic dermatitis, glucocorticosteroids, topical inhibitors of calcineurin.

References

1. Atopic dermatitis. (2016). Adapted clinical guidelines, based on the evidence: 112. http://www.mtd.dec.gov.ua/images/dodatki/…/2016_670_AKN_AD.pdf.

2. Namazova-Baranova LS et al. (2016). Atopic dermatitis in children: current clinical guidelines for diagnosis and therapy. Voprosy sovremennoj pediatrii. 15(3): 279-294.

3. Tamrazova OB et al. (2016). Age evolutionary dynamics of atopic dermatitis. Pediatriya named after GN Speransky. 95(2): 153-159.

4. Balabolkin II, Bulgakova VA. (2011). Allergology of children's age emergency. A guide for physicians. M: Meditsinskoe informatsionnoe agentstvo: 258.

5. Malanicheva TG, Denisova SN, Vahrameeva SN. (2012). Atopic dermatitis in children — basic principles of therapy. Rossijskij vestnik perinatologii i pediatrii. 57(3): 81-89.

6. Diepgen TL. (2002). Early Treatment of the Atopic Child Study Group. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, doubleblind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol. 13: 278-286. https://doi.org/10.1034/j.1399-3038.2002.01047.x; PMid:12390444

7. Guidelines of care for the management of atopic dermatitis. Section 1. Diagnosis and assessment of atopic dermatitis. (2014). J Am Acad Dermatol. 70: 338—351.

8. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. (2014). AAD – American Academy of Dermatology.

9. Guidelines of care for the management of atopic dermatitis: section 3. Diagnosis and assessment of atopic dermatitis. (2014). AAD – American Academy of Dermatology.

10. Guttman-Yassky E, Nograles KE, Krueger JG. (2011). Contrasting pathogenesis of atopic dermatitis and psoriasis – part II: immune cell subsets and therapeutic concepts. J Allergy ClinImmunol. 127(6): 1420—1432. https://doi.org/10.1016/j.jaci.2011.01.054; PMid:21419481

11. Kamer B et al. (2013). Prevalence of atopic dermatitis in infants during the first six months of life: authors’ observations. Advances in Dermatology and Allergology Postpy Dermatologii i Alergologii. 30(5): 277-281.  https://doi.org/10.5114/pdia.2013.38355; PMid:24353486 PMCid:PMC3858654

12. Luger T, De Raeve L, Gelmetti C et al. (2013). Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm. Eur J Dermatol. 23: 758—766. PMid:24185493

13. Sigurgeirsson B, Boznanski A, Todd G et al. (2015). Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics. 135: 597—606. https://doi.org/10.1542/peds.2014-1990; PMid:25802354

14. Nakazato J et al. (2008). Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol. 19: 605—613. https://doi.org/10.1111/j.1399-3038.2007.00692.x

15. SIGN 125. Management of atopic eczema in primary care. (2011).